Three major government agencies are adding new officials to investigate price-gouging in health care — positions experts say will help the three agencies better coordinate across the government.
The new jobs are part of the Biden White House’s new efforts to scrutinize what it calls “corporate greed” in health care.
The Biden administration hasn’t said much about the three new health care counsels, beyond what’s in the initial press release. That announcement spelled out that the new officials will work on two specific areas: investigating private equity’s impact in the health sector, and digging into anti-competitive practices, such as firms “rolling up” small practices in transactions that don’t meet antitrust thresholds. The release cited STAT’s reporting on private equity buying lucrative businesses in controversial autism therapy and travel nursing industries.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.
Already have an account? Log in
Already have an account? Log in
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect